2009
DOI: 10.4049/jimmunol.0900614
|View full text |Cite
|
Sign up to set email alerts
|

Regulation of Airway MUC5AC Expression by IL-1β and IL-17A; the NF-κB Paradigm

Abstract: Mucin over-production is one of the hallmarks of chronic airway diseases such as chronic obstructive pulmonary disease, asthma, and cystic fibrosis. NF-κB activation in airway epithelial cells has been shown to play a positive inflammatory role in chronic airway diseases; however, the role of NF-κB in mucin gene expression is unresolved. In this study, we have shown that the proinflammatory cytokines, IL-1β and IL-17A, both of which utilize the NF-κB pathway, are potent inducers of mucin (MUC)5AC mRNA and prot… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

12
198
2
2

Year Published

2012
2012
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 220 publications
(215 citation statements)
references
References 49 publications
12
198
2
2
Order By: Relevance
“…Partial inhibition of MUC5AC was induced by supernatant from LPS-treated MDM in contrast to the consistent increase of MUC5AC generated by a mix of pro-inflammatory cytokines, as well as by TNF-a and IL-1b alone, at levels found in MDM supernatant. However, our findings are in agreement with reports showing that IL-1b [47][48][49] and TNF-a 47 induce MUC5AC mRNA expression in HBEC. Additionally, significant inhibition of MUC5AC was observed in HBEC treated with supernatant from control MDM, whereas lack of consistent MUC5AC changes were observed in HBEC challenged with cytokines mimicking supernatant from control MDM.…”
Section: Discussionsupporting
confidence: 93%
“…Partial inhibition of MUC5AC was induced by supernatant from LPS-treated MDM in contrast to the consistent increase of MUC5AC generated by a mix of pro-inflammatory cytokines, as well as by TNF-a and IL-1b alone, at levels found in MDM supernatant. However, our findings are in agreement with reports showing that IL-1b [47][48][49] and TNF-a 47 induce MUC5AC mRNA expression in HBEC. Additionally, significant inhibition of MUC5AC was observed in HBEC treated with supernatant from control MDM, whereas lack of consistent MUC5AC changes were observed in HBEC challenged with cytokines mimicking supernatant from control MDM.…”
Section: Discussionsupporting
confidence: 93%
“…We now provide strong evidence that IL13 can act as a secretagogue for MUC5AC in human airway epithelial cells. The magnitude and timing (within an hour) of this effect was similar to the known secretagogue ATP-g-S. Other cytokines such as IL1B (interleukin 1, b) increase MUC5AC production 48 and secretion. 49 However, the effect was delayed for hours or days, suggesting that a secondary pathway was utilized for mucus production.…”
Section: Discussionmentioning
confidence: 69%
“…Besides, periostin is increasingly used as a clinical biomarker for eosinophilic asthma (28). IL-4, IL-5, IL-13, IL-17, IL-33, and TNF-a have all been shown to promote MUC5AC expression and goblet cell hyperplasia, and MUC5AC gene expression hinges on the transcriptional activity of NF-kB (29). IL-4 and IL-13 induce B cells to undergo isotype class switching to IgE production (30), and IgE cross-linking with FcεRI on mast cells leads to mast cell degranulation and bronchoconstriction (31).…”
Section: Discussionmentioning
confidence: 99%
“…IL-17 and G-CSF can contribute to the neutrophilic lung inflammation (33,34), and IL-17 has also been linked to the development of steroid-resistant asthma. The observed anti-inflammatory effects of g-tocotrienol in HDM-induced experimental asthma are likely due to its inhibition on NF-kB activation, as many of those proinflammatory genes encoding for TNF-a, IL-17, MUC5AC, VCAM-1, RANTES, and E-selectin contain the kB site for NF-kB binding within their promoter regions and/or act through NF-kB signaling pathway (4,29).…”
Section: Discussionmentioning
confidence: 99%